Layoffs Accelerate Across Biotech Sector as Companies Refocus Strategies Recent disclosures show a wave of layoffs at multiple biotech firms, including Atara Biotherapeutics, Biomea Fusion, and Mammoth Biosciences. These reductions, ranging from 13% to 35% of staff, reflect ongoing efforts to cut costs and prioritize key drug development programs amid challenging market and regulatory environments.1